Health and Fitness Health and Fitness
Fri, October 7, 2011
[ Fri, Oct 07th 2011 ] - Market Wire
Law Offices of Howard G. Smith LLP Continues Inve .. ation of Pharmaceutical Product Development, Inc.
[ Fri, Oct 07th 2011 ] - Market Wire
Paladin Labs Completes Acquisition of Labopharm
[ Fri, Oct 07th 2011 ] - Market Wire
Advitech and Natunola Announce Completion of Merg .. Private Placement and Change of Name to Botaneco
[ Fri, Oct 07th 2011 ] - Market Wire
Akorn, Inc. Announces Third Quarter 2011 Earnings Release and Conference Call Information
[ Fri, Oct 07th 2011 ] - Market Wire
Cardiovascular Systems Announces Preliminary First-Quarter Financial Results
[ Fri, Oct 07th 2011 ] - Market Wire
Vertex Announces the Date of its Third Quarter 2011 Financial Results Conference Call and Webcast
[ Fri, Oct 07th 2011 ] - Market Wire
MEDNAX 2011 Third Quarter Conference Call/Webcast Scheduled for Tuesday, November 1, 2011
[ Fri, Oct 07th 2011 ] - Market Wire
Expert's Economic Outlook, Global - Equity Resear .. on Impax Laboratories Inc and Enzo Biochem, Inc.
[ Fri, Oct 07th 2011 ] - Market Wire
Expert's Economic Outlook, Global - Equity Resear .. harmaceutical Companies, Inc. and Targacept, Inc.
[ Fri, Oct 07th 2011 ] - Market Wire
Analyst View, Impact of Global Events - Research .. n MELA Sciences, Inc. and SIGA Technologies, Inc.
[ Fri, Oct 07th 2011 ] - Market Wire
Adherex Reports Meeting With FDA's Pediatric Subc .. gs Advisory Committee on the Development of Sodiu
[ Fri, Oct 07th 2011 ] - Market Wire
Senetek Announces Work Plans at Iron Creek Project
Thu, October 6, 2011
[ Thu, Oct 06th 2011 ] - Market Wire
International Drug & Explosives Detection Company .. Signs Marketing Agreement With Tri-Tech Forensics
[ Thu, Oct 06th 2011 ] - Market Wire
American Oriental Bioengineering, Inc. Submitted .. Deficiency with Respect to NYSE Listing Standard
[ Thu, Oct 06th 2011 ] - Market Wire
Dynavax Reports Diabetic Subset Data From Modifie .. the HEPLISAV(TM) Phase 3 Trial in Healthy Adults
[ Thu, Oct 06th 2011 ] - Market Wire
Hansen Medical Announces Settlement of SEC Investigation
[ Thu, Oct 06th 2011 ] - Market Wire
Verisante Issues Update on Regulatory Milestones
[ Thu, Oct 06th 2011 ] - Market Wire
SpectraScience to Introduce WavSTAT4 Optical Biop .. ean Gastroenterology Week Conference in Stockholm
[ Thu, Oct 06th 2011 ] - Market Wire
US Domestic, Global Economic Outlook - Equity Res .. ncare Holdings Inc. and Patterson Companies, Inc.
[ Thu, Oct 06th 2011 ] - Market Wire
US Domestic, Global Economic Outlook - Equity Res .. nomic Health, Inc. and EXACT Sciences Corporation
[ Thu, Oct 06th 2011 ] - Market Wire
US Domestic, Global Economic Outlook - Equity Res .. ratories, Inc. and Quest Diagnostics Incorporated
[ Thu, Oct 06th 2011 ] - Market Wire
MethylGene Appoints Joseph Walewicz as Vice President, Business and Corporate Development
[ Thu, Oct 06th 2011 ] - Market Wire
DiaMedica Named 2011 Emerging Company of the Year by Life Science Association of Manitoba
[ Thu, Oct 06th 2011 ] - Market Wire
Theratechnologies Identifies Second Generation GRF Peptide and Initiates Pre-Clinical Studies
[ Thu, Oct 06th 2011 ] - Market Wire
Patient Home Monitoring Announces Unaudited Reven .. for September 2011, and Growth Figures for Q4 20
[ Thu, Oct 06th 2011 ] - Market Wire
Equity Research on Gilead Sciences Inc. and Human .. . - Regulatory Approval Key for Biotech Companies
[ Thu, Oct 06th 2011 ] - Market Wire
Trimel Provides Update on Female Sexual Dysfunction "Anorgasmia" Clinical Program
[ Thu, Oct 06th 2011 ] - Market Wire
Peregrine Completes Patient Enrollment in Second- .. er Trial;; Data to Be Unblinded in First H
[ Thu, Oct 06th 2011 ] - Market Wire
Novadaq Reports 165 System Shipments During Third Quarter 2011
[ Thu, Oct 06th 2011 ] - Market Wire
Threshold Pharmaceuticals to Present at the BioCentury NewsMakers Conference

Threshold Pharmaceuticals to Present at the BioCentury NewsMakers Conference


Published on 2011-10-06 03:24:22 - Market Wire
  Print publication without navigation


October 06, 2011 06:00 ET

Threshold Pharmaceuticals to Present at the BioCentury NewsMakers Conference

SOUTH SAN FRANCISCO, CA--(Marketwire - Oct 6, 2011) - Threshold Pharmaceuticals, Inc. (NASDAQ: [ THLD ]) today announced that Dr. Barry Selick, Threshold's Chief Executive Officer, is scheduled to present at the 2011 BioCentury NewsMakers in the Biotech Industry Conference in New York City on Friday, October 21, 2011 at 11:00 AM EDT.

A live webcast of the presentation will be available under the Webcast section of the Company's Website at [ www.thresholdpharm.com ]

About Threshold Pharmaceuticals

Threshold is a biotechnology company focused on the discovery and development of drugs targeting Tumor Hypoxia, the low oxygen condition found in microenvironments of most solid tumors as well as the bone marrows of some hematologic malignancies. This approach offers broad potential to treat a variety of cancers. By selectively targeting tumor cells, we are building a pipeline of drugs that hold promise to be more effective and less toxic to healthy tissues than conventional anticancer drugs. For additional information, please visit our website ([ www.thresholdpharm.com ]).


Contributing Sources